Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line

Unlock unlimited access to all IAM content